The Stakeholder Imperative  by Smith, Joseph M.
p
s
c
f
r
s
s
E
c
t
a
p
t
r
c
a
t
n
b
n
o
w
t
nThe Stakeholder Imperative
Joseph M. Smith, MD, PhD, FACCIntroduction
On a national level, U.S. healthcare costs of morethan $2.7 trillion/year consume nearly 18% ofour gross domestic product (GDP) and chal-
lenge our economic viability, international competitive-
ness, and evenour national security.1 Yet they continue to
grow. The average employer spends nearly $12,000 per
employee on healthcare coverage, an economic burden
the employer struggles to pass on to customers.2 In addi-
tion, the average family spends $1115 on insurance pre-
miums and $235 on out-of-pocket healthcare expenses
eachmonth.3 A recent projection estimates that, by 2030,
the combined cost of family insurance premiums and
out-of-pocket expenses will exceed average family in-
come.4 Clearly, change in both healthcare delivery and
ayment systems are imminent and inevitable, and every
takeholder has a separate but vital role to play in this
oming transformation.
One element common to all stakeholders is the need
or data—what we term “actionable information.” The
ecent mandate for electronic health records (EHRs) is
upporting increased access to medical data that some
takeholders can use to address healthcare challenges.
xpectations are increasing for Learning Health Systems,
omparative-effectiveness research (CER), and price
ransparency, all of which can provide not just unfettered
ccess to data but unassailable cues for actions that can
referentially impact today’s unsustainable cost trajec-
ory. We echo the guidance given by the recent IOM
eport5 that: “Developing a continuously learning health-
are system is critical for the future of health care, as well
s for the future physical and fınancial health of the na-
ion. There is no simple path forward; rather, actions
eed to be taken by every stakeholder if this vision is to
ecome a reality. Such concerted action will enable the
ation’s healthcare system to evolve to one that continu-
usly learns and improves, fınally providing Americans
ith best care at lower cost.”
In this context, wireless technology provides a near-
erm opportunity. This ubiquitous, low-cost telecommu-
ications infrastructure, which has proven instrumental
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Spring), has the potential for a similar impact on educa-
tion, interaction, and collaboration in the context of
health care. Its unprecedented scale and ease of use can
enable “jail-breaking” of healthcare, facilitating the ex-
change of critical information across the entire healthcare
enterprise, independent of today’s costly, ineffıcient, and
centralized and heavily siloed healthcare infrastructure
consisting of hospitals and doctors’ offıces. But it must be
clear from the outset that technology, in this instance
wireless technology, is simply the means to the required
end of lower healthcare cost.
Although actionable information is necessary for
healthcare reform, it is far from suffıcient. True reform
will take place only once stakeholders, armed with this
information, are mobilized and incentivized to use this
asset to participate, innovate, anddrivemeaningful trans-
formation, if not full-blown revolution. But the need to
educate; enable; engage (even at times enrage); and ap-
propriately incentivize the various stakeholders (in par-
ticular, the American public) remains a daunting task.
Additionally, although each stakeholder plays an es-
sential role in addressing this challenge, the specifıcs sur-
rounding each role are certain to evolve as reform takes
place. How patients, physicians, payers, private industry,
government, and entrepreneurs react to healthcare inno-
vation and change will doubtlessly encourage or force
other changes that, in aggregate, will chart the path
forward. Offered in the context of military engage-
ment, the sentiment that “no battle plan survives con-
tact with the enemy” is evenmore true in health care, as
the enemy in this case—excessive costs—has many
and varied constituents.
West Health
Starting in early 2009, two successful entrepreneurs, Gary
andMaryWest, took on the focused challenge of working
to lower healthcare costs. Their initial efforts resulted in
the formation of a nonprofıt, nonpartisan medical re-
search organization now known as the West Health In-
stitute. The institute’s mission is to lower healthcare costs
through technology and innovation.
The Wests also recognized the need to engender a
public policy environment conducive to the creation and
adoption of innovative cost-cutting solutions in health
care. That led them to found the West Health Policy
Medicine Am J PrevMed 2013;44(1S1):S1–S4 S1
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S2 Smith / Am J Prev Med 2013;44(1S1):S1–S4Center, a nonprofıt, nonpartisan organization with the
same aim as the Institute. The Center conducts indepen-
dent, nonpartisan research and analysis and serves as a
neutral convener among healthcare providers, insurers,
government agencies, drug and device manufacturers,
and other healthcare system participants.
The Center’s work to promote research, convene
stakeholders, and educate broadly focuses on the follow-
ing themes shared by all of the West Health organiza-
tions: (1) advancing cost-effective models of care;
(2) promoting practical and actionable healthcare policy;
(3) liberating healthcare data; and (4) creating an effıcient
medical marketplace. A cornerstone of the Washing-
ton DC–based Center is to provide policymakers with
proposals that can result in at least $100 billion in
savings over the next 10 years. One early tactic em-
ployed by the Center to advance this goal is competi-
tive selection of independent policy fellows whose re-
search is meant to enable subtle changes in policy or
regulation that, in aggregate, will result in signifıcant
healthcare cost-savings.
A third organization, the West Health Investment
Fund, similarly established with the aim of lowering
healthcare costs, provides capital to start-up companies
with disruptive healthcare technologies and services tar-
geting cost reduction. Finally, the fourth organization
within the collective initiative is theWest Health Incuba-
tor, which supports the incubation and accelerated devel-
opment of start-up companies focused on innovative so-
lutions to lower healthcare costs.
Each organization within West Health functions as a
separate vehicle, although, in concert, all work to use all
necessary levers to create a synergistic ecosystem to effec-
tively lower healthcare costs.
Organization of This Supplement
The papers in this supplement to theAmerican Journal of
Preventive Medicine represent one effort from West
Health to engage leaders across the spectrum of U.S.
health care.6–18
Those whose articles appear here were charged with
the task of describing shifting developments, emerging
opportunities, challenging barriers, unique capabilities,
and pioneering initiatives in addressing the crisis of cost
in U.S. health care.
In the fırst article,6 “A Role for Data,” Meier describes
the implications of better capture, analysis, and dissemi-
nation of data for healthcare stakeholders. Specifıcally,
stakeholders appreciate the benefıts and power of data—
with its potential to increase value through predictive
analytics and prevention—andwant to take better advan-
tage of it. Accordingly, increasing access to data and
creating incentives to develop and encourage adoption oftechnology are necessary steps to achieve cost-savings.
Our current system, with physicians/providers at the
center, in fact, is choked with data that are ineffıciently
and incompletely utilized. This paper calls for much
more sophisticated data management systems to make
the best thing to do also the easiest in assisting all
decision makers.
In “A Role for Research,” Olchanski and co-authors7
discuss the potential economic impact of CER. They ar-
gue that the substantial gap in the health economic liter-
ature on preventive care can be addressed as data become
more available and more readily accessible by agencies
dedicated to patient-centric CER. In turn, data-driven
CER research will be able to influence policy decisions
and align fınancial incentives for stakeholders. They con-
clude by noting that researchers will be able to meaning-
fully study more and larger populations across more
types of settings and funding sources.
In “A Role for Patients,” Sarasohn-Kahn8 discusses the
ncreasing interest and engagement of patients in their
wn health care through the use of technology. She re-
iews different options that patient-consumers have ex-
lored and briefly argues the economic benefıts. Notably,
he advocates for the importance of changing workflows
nd incentive structures.
In “A Role for Physicians,” Shah9 argues for a
round-up approach to cost containment driven by the
hysicians themselves. Specifıcally, costs can be ad-
ressed through a nationalmandate for accountable care,
n emerging market for price transparency, and the dis-
uptive promise of mobile and other information tech-
ologies. Shah also explores the ethos of physicians mak-
ng decisions involving consideration of costs.
In “A Role for Payers,” Tuckson10 discusses strategies
hat payers have used to combat the rising cost of health
are. Specifıcally, he discusses the Learning Health Sys-
em, which addresses quality and cost-effectiveness
hrough the collection of aggregate health data from
iverse sources, application of advanced analytics to
ranslate data into actionable information, dissemina-
ion of that information to enhance decision making,
nd constant feedback to ensure continuous perfor-
ance improvement.
In “A Role for Private Industry,” Isaac11 discusses the
benefıts of corporate wellness programs and examines
Johnson & Johnson’s program Live for Life. He found
that providing employees the voluntary opportunity to
access preventive care improved employee health, re-
duced absenteeism rates, and reduced the cost of the
company’s healthcare cost obligations.Moreover, the use
of technology has opened the door to evenmore effective
means of providing preventive care.
www.ajpmonline.org
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Smith / Am J Prev Med 2013;44(1S1):S1–S4 S3In “A Role for Government,” Straube12 discusses the
ole of the government in preventive care and how it can
rive cost-savings. Specifıcally, through smart Medi-
are policies, the government can influence Medicaid,
he Children’s Health Insurance Program (CHIP), and
rivate-sector payers by promoting prevention ser-
ices, addressing public health issues, and improving
ealthcare quality and value.
In “A Role for Entrepreneurs,” Gottlieb and Ma-
ower13 explore questions surrounding technology’s
ost–benefıt analysis in health care. They argue that the
learest way to solve long-term fıscal challengeswith pub-
ic health programs like Medicare and Medicaid is to
mprove healthcare productivity. Central to their discus-
ion is the long-term measurement of cost-savings en-
bled by medical devices versus the impact they have on
atient health. They highlight that entrepreneurs are in-
reasingly being required to demonstrate at the outset
hat their inventions can lower direct medical costs in
rder to secure reimbursement for their use. This re-
uirement has gone one step further in becoming a com-
on criterion upon which prototype technologies are
udged by potential investors.
In addition, this supplement includes two case stud-
es.14,15 Pettigrew14 describes the Senior Community
enters of SanDiego andhow they can be used as amodel
or cost-effective preventive care. Yazdi15 discusses how
est to educate entrepreneurs to fıx the healthcare system,
escribing the Center for Bioengineering Innovation and
esign at The Johns Hopkins University, which trains its
tudents to bridge the gap between innovation and med-
cal practice.
The supplement also includes one commentary article
n which Frakt and Carroll16 discuss the quality impera-
ive and howwhat we already know could be used to save
he U.S. healthcare system.
The articles in this supplement,6–18 taken together
with the commentaries and case studies, offer valuable
insight into stakeholder initiatives, describing the full
spectrum of roles that the essential stakeholders can and
must play in lowering the cost of health care. It is ex-
tremely encouraging that despite the magnitude of the
shared challenge to lower the cost of health care to a point
where it becomes economically sustainable, and the dif-
ferent and potentially competing or conflicting agendas
by the different stakeholders, there is agreement that the
liberation of healthcare data is essential to each and every
stakeholder, and that the maturation of that data from its
raw forms into the progressively refıned entities of infor-
mation, understanding, wisdom, and ultimately unassail-
able cues for action is not only essential but also within
reach.
January 2013The race is on to clear the path for innovators in this
country who want to create a new paradigm, an
infrastructure-independent model of healthcare delivery
that frees health care from the traditional, expensive, and
ineffıcient confınes of hospitals, emergency rooms, phy-
sician offıces, and clinics and effectively decentralizes and
democratizes health care. A much less costly, and yet
more immediate, more accessible, more responsive, and
more ambient form of health care is in sight, made possi-
ble by technologic innovations that have transformed
other industries; we all have a role to play. To paraphrase
a quote attributed to Dr. Paul Janssen, the founder of
Janssen Pharmaceuticals, “we have no time to waste, be-
cause patients are waiting.”
Publication of this article was supported by the West Health
Initiative.
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Did you know?
The latest AJPM news is available online.
Visit www.ajpmonline.org to see the “News from
AJPM” section on the homepage.www.ajpmonline.org
